Schuiveling, M., Tonk, E. H. J., Verheijden, R. J., & Suijkerbuijk, K. P. M. (2020). Hyperprogressive disease rarely occurs during checkpoint inhibitor treatment for advanced melanoma. Cancer Immunol Immunother.
Chicago Stili AlıntıSchuiveling, M., E. H. J. Tonk, R. J. Verheijden, ve K. P. M. Suijkerbuijk. "Hyperprogressive Disease Rarely Occurs During Checkpoint Inhibitor Treatment for Advanced Melanoma." Cancer Immunol Immunother 2020.
MLA AlıntıSchuiveling, M., E. H. J. Tonk, R. J. Verheijden, ve K. P. M. Suijkerbuijk. "Hyperprogressive Disease Rarely Occurs During Checkpoint Inhibitor Treatment for Advanced Melanoma." Cancer Immunol Immunother 2020.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..